Anthem may sacrifice biz lines to get its Cigna deal
No one is sure whether Anthem and the Justice Department can hash out a settlement before the federal case to block the insurer's $54 billion acquisition of Cigna Corp. goes to trial in November.
Health Care & Insurance
Articles
Aetna to quit most Obamacare markets, joining major rivals
The decision by Aetna is the latest blow to President Obama’s signature domestic policy law. While it has brought coverage to millions, the new markets have proven volatile for some of the largest for-profit insurers.
Aisle 6, Row 3, Bin 12: IU Health gears up for new, high-tech warehouse
Supplies are the second-largest expense for hospitals. Here’s how Indiana’s largest health system plans to keep its 15 hospitals stocked in bandages and medical supplies.
Anthem suffers setback in bid for Cigna decision by year-end
Anthem Inc. will go to trial against the U.S. in late November to defend its $48 billion takeover of rival insurer Cigna Corp., a start date later than Anthem said it needed to potentially close the deal by an April deadline.
Anthem, Cigna shares rise after U.S. says it’s open to settlement
Investors appeared emboldened by remarks from a Justice Department lawyer Friday that the government was willing to hear settlement offers in its antitrust case involving the merger of the two insurers.
Indiana gets D-minus for family-workplace laws
Starting a family and want a few months of paid leave? How about paid medical leave for pregnancy-related disabilities. You might consider living in New York or California, rather than Indiana, a national group says.
Aetna judge hands off Anthem merger case to speed trials
The Anthem-Cigna case was assigned to Judge Amy Berman Jackson, who was appointed to the bench by President Barack Obama. She set a scheduling conference for Aug. 12
Cigna talks about Plan B as U.S. challenge to Anthem bid looms
Cigna Corp. CEO David Cordani faces a tough task: persuading investors and lawyers that the health insurer is committed to a $48 billion takeover by Indianapolis-based Anthem Inc., while also talking up its prospects as an independent company.
Big drug firms eye potential $7.2B animal vaccine market
Companies like Eli Lilly and Co. unit Elanco are focused on developing vaccines as alternatives to antibiotics.
Cialis users sue Lilly, claiming drug has ties to skin cancer
Seven men who took Cialis pills to treat erectile dysfunction sued Indianapolis drugmaker Eli Lilly and Co. this week, claiming they later suffered from skin cancer that was related to the medicine.
Anthem says Cigna deal at risk without merger ruling by year-end
Anthem’s lawyer, Christopher Curran, told U.S. District Judge John Bates in Washington, D.C., on Thursday that Cigna’s top management is "no longer interested in being pursued."
AIT meltdown derails huge Marian gift
Five years after pledging an astounding $48 million to help Marian University build a medical school, an Indianapolis businessman has paid only about one-fifth of that amount.
Baldwin & Lyons’ earnings rise on record premiums
The earnings report was the first for the Carmel-based trucking insurer since it experienced a massive overhaul of senior management in May.
Aetna’s Obamacare reversal latest blow to U.S. health law
Health care insurance giant Aetna Inc., facing more than $300 million in losses from Affordable Care Act health plans this year, may exit Obamacare markets.
CNO says assets hard to value at Platinum-linked insurer trusts
CNO Financial shares dropped 2.8 percent Monday morning after declining 5.5 percent last week. The Carmel-based insurer said last week that it was scrutinizing a risk-transfer arrangement with Beechwood Re, the reinsurer linked to embattled hedge fund Platinum Partners.
Anthem seeks big rate increase in Connecticut
Indianapolis-based Anthem Inc. has asked for an average 26.8 percent rate increase for individual plans offered on and off the state's health insurance exchange.
Indiana continues to lead U.S. in pharmacy robberies
There were more pharmacy robberies in Indiana last year than California, which has a population about six times larger.
Incoming Lilly CEO pick to focus globally
Dave Ricks will begin guiding the company during a period of relative calm compared with the trying times John Lechleiter navigated during his eight years at the helm.
‘Smooth transition’ predicted as Lilly turns to experienced exec
Over the last eight years, Eli Lilly relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now, it’ll rely on another long-time executive for its next chapter.
Anthem prepping for hardball fight with feds over Cigna deal
The Indianapolis-based health insurer said its participation in the government’s health insurance exchanges—a sore subject for the Obama administration that is trying to stop the acquisition—may be at stake.